1. Home
  2. PRPO vs EVAX Comparison

PRPO vs EVAX Comparison

Compare PRPO & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precipio Inc.

PRPO

Precipio Inc.

N/A

Current Price

$23.30

Market Cap

42.0M

Sector

Industrials

ML Signal

N/A

Logo Evaxion Biotech

EVAX

Evaxion Biotech

N/A

Current Price

$3.15

Market Cap

29.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PRPO
EVAX
Founded
N/A
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.0M
29.7M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
PRPO
EVAX
Price
$23.30
$3.15
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $11.25
AVG Volume (30 Days)
★ 120.8K
39.7K
Earning Date
11-13-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 92.15
N/A
EPS
N/A
★ N/A
Revenue
★ $24,049,000.00
N/A
Revenue This Year
$233.72
N/A
Revenue Next Year
$22.61
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 29.77
N/A
52 Week Low
$16.40
$2.77
52 Week High
$33.63
$12.15

Technical Indicators

Market Signals
Indicator
PRPO
EVAX
Relative Strength Index (RSI) N/A 53.44
Support Level N/A $2.87
Resistance Level N/A $3.33
Average True Range (ATR) 0.00 0.13
MACD 0.00 0.01
Stochastic Oscillator 0.00 71.43

Price Performance

Historical Comparison
PRPO
EVAX

About PRPO Precipio Inc.

Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: